Neuberger Berman Group LLC Roivant Sciences Ltd. Put Options Transaction History
Neuberger Berman Group LLC
- $118 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ROIV
# of Institutions
265Shares Held
489MCall Options Held
565KPut Options Held
1.68M-
Sb Investment Advisers (Uk) LTD London, X073MShares$822 Million7.6% of portfolio
-
Viking Global Investors LP69.4MShares$780 Million2.78% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$751 Million65.04% of portfolio
-
Black Rock Inc. New York, NY36.2MShares$407 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.6MShares$401 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.92B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...